The most important healthcare story of 2020 was COVID-19, without a doubt. It was an event with few peers, and it challenged some parts of the sector while elevating others.
And in one way or another, COVID likely will have an impact on many of 2021’s best healthcare stocks.
By mid-November 2020, the globe had suffered 57 million coronavirus cases causing nearly 1.4 million deaths. That includes 11.6 million cases here in the U.S. that have so far claimed the lives of 250,000 Americans. That’s not to mention the additional adverse health effects the virus has had on millions of survivors.
Naturally, then, there are two types of healthcare companies that stand out as the biggest potential winners of 2021: companies that are able to produce a widely used vaccine or treatment for the virus, and resilient firms that held tough through the worst and can benefit from a gradual return to normalcy.
Here, we explore 13 of the best healthcare stocks to buy for 2021. Some of these picks are in the later stages of developing COVID products, while others sport business models that are designed to do well in most market conditions (but should enjoy a bump when the virus finally begins to recede).